Further, the use of MMP-2-selective near-infrared probes showed that MMP-2, as opposed to other MMPs expressed in the tumor–bone microenvironment such as MMP-13, were selectively inhibited by the administered BMMPIs [113]. This evidence concerns the gene MMP2 and neoplasm.